CJL
CVS icon

Cyrus J. Lawrence’s CVS Health CVS Stock Holding History

Cyrus J. Lawrence’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-486
Closed -$21K – 79
2024
Q4 		$21K Sell
486
-1,305
-73% -$73.2K ﹤0.01% 148
2024
Q3 		$112K Sell
1,791
-3,923
-69% -$229K 0.02% 80
2024
Q2 		$337K Sell
5,714
-96,902
-94% -$6.06M 0.07% 57
2024
Q1 		$8.19M Buy
+102,616
New +$7.84M 1.82% 24
2023
Q3 		$1.81M Sell
25,867
-279
-1% -$19.8K 0.5% 42
2023
Q2 		$1.81M Sell
26,146
-89,833
-77% -$6.39M 0.39% 40
2023
Q1 		$8.62M Sell
115,979
-2,423
-2% -$203K 2.51% 11
2022
Q4 		$11M Sell
118,402
-2,314
-2% -$223K 3.29% 4
2022
Q3 		$11.5M Sell
120,716
-2,649
-2% -$262K 2.26% 8
2022
Q2 		$11.4M Sell
123,365
-1,140
-0.9% -$111K 3.3% 5
2022
Q1 		$12.6M Buy
+124,505
New +$13.1M 2.88% 8

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Cyrus J. Lawrence's CVS Position: Q1 2025 in Review

Cyrus J. Lawrence sold out of CVS Health (CVS) in Q1 2025, closing a stake of 486 shares — an estimated $21K sold.

Cyrus J. Lawrence first reported a position in CVS in Q1 2022 and held it in 11 quarters. The position peaked at $12.6M in Q1 2022. 1,756 funds tracked by Wall St. Rank hold CVS as of Q1 2025.

  • Cyrus J. Lawrence reported no remaining CVS Health position as of Q1 2025 after selling out during the quarter.
  • Cyrus J. Lawrence sold 486 CVS Health shares in Q1 2025, an estimated $21K.
  • Cyrus J. Lawrence first reported a position in CVS Health in Q1 2022 and held it in 11 quarters.
  • Cyrus J. Lawrence's CVS Health position peaked at $12.6M in Q1 2022.
  • 1,756 funds tracked by Wall St. Rank held CVS Health as of Q1 2025.

Based on Cyrus J. Lawrence's 13F filing for Q1 2025, filed 15 May 2025.